IMMUCELL CORP /DE/ (ICCC)
Data as of , from SEC Form 4 filings.
See up to 3 months of ICCC. The 7-day demo opens the 1M and 3M ranges and puts ICCC on your watchlist.
Start 7-day demoLatest ICCC insider trades
About IMMUCELL CORP /DE/ (ICCC)
The SEC lists IMMUCELL CORP /DE/ under CIK 0000811641, in in vitro and in vivo diagnostic substances. It is grouped with Health Care companies on this site.
ICCC Form 4 activity by transaction type, last 90 days
No Form 4 activity for ICCC in the last 90 days.
ICCC insider transactions (Form 4)
2419 Form 4 filings on record, the earliest from Nov 12, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Boekhorst Paul Francis Olivier Te - Officer | Open-market purchase | Common Stock, par value $.01 per share | 8,000 | $9.50 | $76K | |
| Kathy V. Turner - Director | Grant or award | Non Qualified Stock Options (Right to buy) | 17,899 | $0.00 | - | |
| David Scott Tomsche - Director | Grant or award | Non Qualified Stock Options (Right to buy) | 11,933 | $0.00 | - | |
| Gloria F. Basse - Director | Grant or award | Non Qualified Stock Options (Right to buy) | 11,933 | $0.00 | - | |
 Paul R. Wainman - Director | Grant or award | Non Qualified Stock Options (Right to buy) | 11,933 | $0.00 | - | |
 Bryan K. Gathagan - Director | Grant or award | Non Qualified Stock Options (Right to buy) | 10,000 | $0.00 | - | |
| Paul R. Wainman - Director | Grant or award | Non Qualified Stock Options (Right to buy) | 10,000 | $0.00 | - | |
| David Scott Tomsche - Director | Grant or award | Non Qualified Stock Options (Right to buy) | 10,000 | $0.00 | - | |
| Bobbi Jo Brockmann - Officer | Grant or award | Incentive Stock Options (Right to buy) | 5,000 | $0.00 | - | |
 Steven T. Rosgen - Director | Grant or award | Non Qualified Stock Options (Right to buy) | 10,000 | $0.00 | - | |
| Gloria F. Basse - Director | Grant or award | Non Qualified Stock Options (Right to buy) | 10,000 | $0.00 | - | |
| Michael F. Brigham - Director | Option exercise | Stock Options (right to buy) | 25,000 | $0.00 | - | |
| Michael F. Brigham - Director | Option exercise | Common Stock, par value $.01 per share | 25,000 footnote F1 | $5.84 | $146K | |
| Michael F. Brigham - Director | Tax withholding / forfeiture | Common Stock, par value $.01 per share | 24,052 footnote F2 | $6.07 | $146K | |
| ||||||
| Boekhorst Paul Francis Olivier Te - Officer | Grant or award | Stock Options (right to buy) | 109,500 | $0.00 | - | |
| Timothy C. Fiori - Officer | Grant or award | Stock Options (right to buy) | 120,000 | $0.00 | - | |
| Bobbi Jo Brockmann - Officer | Grant or award | Stock Options (right to buy) | 100,000 | $0.00 | - | |
| Boekhorst Paul Francis Olivier Te - Officer | Grant or award | Stock Options (right to buy) | 110,000 | $0.00 | - | |
| Boekhorst Paul Francis Olivier Te - Officer | Open-market purchase | Common Stock $0.10 par value per share | 3,708 | $4.87 | $18K | |
| Boekhorst Paul Francis Olivier Te - Officer | Open-market purchase | Common Stock $0.10 par value per share | 2,556 | $5.00 | $13K | |
| Boekhorst Paul Francis Olivier Te - Officer | Open-market purchase | Common Stock $0.10 par value per share | 3,521 | $5.04 | $18K | |
| David Scott Tomsche - Director | Open-market purchase | Common Stock $0.10 par value per share | 1,633 | $4.76 | $8K | |
| David Scott Tomsche - Director | Open-market purchase | Common Stock $0.10 par value per share | 1,633 | $4.77 | $8K | |
| Boekhorst Paul Francis Olivier Te - Officer | Grant or award | Stock Options (right to buy) | 74,277 | $6.10 | $453K | |
ICCC insider trading FAQ
What is the latest insider trade for ICCC?
IMMUCELL CORP /DE/ (ICCC) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-22. The full record for ICCC runs to 19 Form 4 filings, the earliest from 2025-11-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ICCC stock?
No insider purchases of ICCC were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling ICCC stock?
No insider sales of ICCC were filed in the last 90 days.
Where can I see ICCC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ICCC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Boekhorst Paul Francis Olivier Te view on EDGAR
- - Kathy V. Turner view on EDGAR
- - David Scott Tomsche view on EDGAR
- - Gloria F. Basse view on EDGAR
- - Paul R. Wainman view on EDGAR
- - Bryan K. Gathagan view on EDGAR
- - Paul R. Wainman view on EDGAR
- - David Scott Tomsche view on EDGAR
- - Bobbi Jo Brockmann view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ICCC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ICCC with a 7-day demo
- ICCC on your watchlist
- Every ICCC Form 4 filing on record
- Up to 3 months of ICCC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
